CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was up 0.4% on Tuesday . The company traded as high as C$4.63 and last traded at C$4.63. Approximately 443 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 4,401 shares. The stock had previously closed at C$4.61.
CSPC Pharmaceutical Group Price Performance
The business’s fifty day moving average is C$4.80 and its two-hundred day moving average is C$4.53.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Featured Stories
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
